Dysregulation of miR-335-5p in People with Obesity and its Predictive Value for Metabolic Syndrome
Hormone and Metabolic Research · 01.10.2024 · 56 (10) · 749-755
DOI: 10.1055/a-2261-8115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.10.2024. Verfasst von Liting Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology, The People's Hospital of Longhua, Shenzhen, China. Hauptthemen laut MEDLINE: MicroRNAs, Metabolic Syndrome, Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
The epidemic of obesity and metabolic syndrome has become the most serious global public health problem. The part played by microRNA (miRNA) in the onset and progression of obesity and metabolic syndrome has been increasingly focused upon. The goal of this study was to explore miR-335-5p as a potential predictive biomarker or therapeutic target for obesity and metabolic syndrome. The expression level of miR-335-5p was detected by qRT-PCR. The diagnostic value of miR-335-5p was evaluated by ROC curve. The association between serum miR-335-5p levels and various clinical parameters was assessed using the chi-square test. Logistic regression analysis was used to evaluate the risk factors of metabolic syndrome in obese population. The biological processes and molecular mechanisms are studied through GO and KEGG enrichment analysis. The ROC curve analysis revealed that miR-335-5p could serve as a predictive indicator for the development of obesity accompanied by metabolic syndrome. Logistic regression analysis revealed that BMI, TG, FBG, HOMA-IR, and miR-335-5p expression represent independent risk factors of metabolic syndrome occurrence. Chi-square test analysis revealed that patients with higher values of BMI, SBP, DBP, TG, FBG, and HOMA-IR exhibited a more significantly increased expression of miR-335-5p in their serum. In conclusion, miR-335-5p holds predictive and diagnostic value for obesity and metabolic syndrome and has potential to serve as a biomarker for these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endocrinology, The People's Hospital of Longhua, Shenzhen, China.
- Minzhi Community Health Service Center, The People's Hospital of Longhua, Shenzhen, China.
Zitieren
APA
Lu, L., & He, Y. (2024). Dysregulation of miR-335-5p in People with Obesity and its Predictive Value for Metabolic Syndrome. Hormone and Metabolic Research, 56(10), 749-755. https://doi.org/10.1055/a-2261-8115
Vancouver
Lu L, He Y. Dysregulation of miR-335-5p in People with Obesity and its Predictive Value for Metabolic Syndrome. Hormone and Metabolic Research. 2024;56(10):749-755. doi:10.1055/a-2261-8115
BibTeX
@article{Lu2024,
author = {Lu, Liting and He, Yufeng},
title = {Dysregulation of miR-335-5p in People with Obesity and its Predictive Value for Metabolic Syndrome},
journal = {Hormone and Metabolic Research},
year = {2024},
volume = {56},
number = {10},
pages = {749--755},
doi = {10.1055/a-2261-8115}
}
EUVIMED